Ippolito, Luigi https://orcid.org/0000-0001-7927-8555
Duatti, Assia
Iozzo, Marta https://orcid.org/0000-0003-2533-6646
Comito, Giuseppina
Pardella, Elisa https://orcid.org/0000-0001-5655-6428
Lorito, Nicla
Bacci, Marina https://orcid.org/0000-0001-8506-2179
Pranzini, Erica https://orcid.org/0000-0002-1668-2777
Santi, Alice
Sandrini, Giada https://orcid.org/0000-0002-7294-3863
Catapano, Carlo V https://orcid.org/0000-0002-7079-557X
Serni, Sergio
Spatafora, Pietro https://orcid.org/0000-0003-0207-0160
Morandi, Andrea https://orcid.org/0000-0002-9222-5332
Giannoni, Elisa https://orcid.org/0000-0001-7136-1098
Chiarugi, Paola https://orcid.org/0000-0001-7655-2969
Funding for this research was provided by:
Fondazione AIRC per la ricerca sul cancro ETS (19515)
Fondazione AIRC per la ricerca sul cancro ETS (24731)
Fondazione AIRC per la ricerca sul cancro ETS (22941)
Fondazione AIRC per la ricerca sul cancro ETS (26599)
Swiss Cancer League (KLS-4899-08-2019)
Fondazione Ticinese Ricerca sul Cancro
European Union, National Recovery and Resilience Plan, Mission 4 Component 2 - Investment 1.4 - National Center for Gene Therapy and Drugs based on RNA Technology - NextGenerationEU (CN00000041)
European Union, National Recovery and Resilience Plan, Mission 4 Component 2, Creation and strengthening of "innovation ecosystems", construction of "territorial R&D leaders" (ECS_00000017)
Fondazione Pezcoller
Article History
Received: 12 July 2023
Revised: 30 May 2024
Accepted: 7 June 2024
First Online: 21 June 2024
Disclosure and competing interests statement
: The authors declare no competing interests.